Duodenal-jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats [0.03%]
十二指肠-空肠旁路手术通过激活AMPK通路活化eNOS并增强抗氧化系统以改善糖尿病心肌病大鼠心脏氧化应激状态
Guangwei Yang,Zitian Liu,Shuohui Dong et al.
Guangwei Yang et al.
Background: Diabetic cardiomyopathy is a serious complication of obesity with type 2 diabetes and is a major cause of mortality. Metabolic surgery, such as duodenal-jejunal bypass (DJB), can effectively improve diabetic c...
Association of methylation risk score with incident type 2 diabetes mellitus: A nested case-control study [0.03%]
甲基化风险评分与2型糖尿病发病的关系：一项病例对照研究
Weifeng Huo,Huifang Hu,Tianze Li et al.
Weifeng Huo et al.
Aims: To investigate the association of methylation risk score (MRS) and its interactions with environmental factors with type 2 diabetes mellitus (T2DM) risk. ...
Ubiquitin-conjugating enzyme E2 for regulating autophagy in diabetic cardiomyopathy: A mini-review [0.03%]
自噬在糖尿病心肌病中的泛素连接酶E2：综述
Yueran Zhou,Zequn Zheng,Shenglin Wu et al.
Yueran Zhou et al.
The prevalence of diabetic cardiomyopathy (DCM) increases year by year with the increase in the prevalence of diabetes mellitus (DM), which is one of the most serious cardiovascular complications of DM and a major cause of death in diabetic...
Tomoyuki Kawada
Tomoyuki Kawada
Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease [0.03%]
血肌红蛋白与2型糖尿病肾病的关系
Lin Yang,Yan Shen,Wenxiao Li et al.
Lin Yang et al.
Background: Diabetic kidney disease (DKD) is the most frequent complication in patients with type 2 diabetes mellitus (T2DM). It causes a chronic and progressive decline in kidney function, and ultimately patients require...
Lipocalin 2-A bone-derived anorexigenic and β-cell promoting signal: From mice to humans [0.03%]
脂联素2-一种骨源性的抑食和β细胞促生长信号：从小鼠到人类研究
Yuying Yang,Jianmin Liu,Stavroula Kousteni
Yuying Yang
The skeleton is traditionally known for its structural support, organ protection, movement, and maintenance of mineral homeostasis. Over the last 10 years, bone has emerged as an endocrine organ with diverse physiological functions. The two...
Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis [0.03%]
基于全面生物信息学分析的二型糖尿病外周神经病变诊断标志物研究
Xiaoyu Chen,Qingquan Liu,Niyao Chen et al.
Xiaoyu Chen et al.
Background: Diabetic peripheral neuropathy (DPN) is a common complication of Type 2 diabetes mellitus (T2DM), which frequently results in disabling neuropathic pain and lower-limb amputation. The identification of noninva...
Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 [0.03%]
基于全球疾病负担研究（2019）的高空腹血糖归因于气管、支气管和肺癌的全球、区域和国家疾病负担系统分析
Minmin Wang,Jingyi Liu,Jia Wang et al.
Minmin Wang et al.
Background: Tracheal, bronchus, and lung (TBL) cancer is the third most common and lethal type of cancer worldwide. Glucose metabolism disorders, as represented by high fasting plasma glucose (HFPG), increase the risk of ...
Lower urinary albumin-to-creatinine ratio predicted all-cause and cardiovascular mortality in Chinese population with diabetes and prediabetes-The Shanghai Changfeng cohort study [0.03%]
上海changfeng队列研究：尿微量白蛋白与肌酐比值与糖尿病和糖耐量异常人群的总死亡率和心血管疾病死亡率的相关性研究
Lingyan Chen,Li Wu,Qian Li et al.
Lingyan Chen et al.
Introduction: Elevated urinary albumin-to-creatinine ratio (UACR) was associated with increased mortality in general population and diabetic patients. However, whether the association remains similar in the subjects with ...
Out of stock: A brief clinical reference for rough equivalency of glucagon-like peptide-1 (GLP-1) ± glucose-dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetes [0.03%]
缺货：简要的临床参考用于糖化血红蛋白(A1C)和体重减轻的肽-1(GLP-1)±葡萄糖依赖性促胰岛素多肽(GIP)受体激动剂的粗糙等效性
Leigh Perreault,Bryan C Bergman
Leigh Perreault
Highlights Despite the common practice of switching patients from one medicine to another—to improve efficacy, safety, or tolerability—guidance on how to do so is uncommon. During this time of global shortage of glucagon‐like peptide‐1 ...